Today's Daily Dose brings you news about AstraZeneca pausing its phase 3 study of COVID-19 vaccine candidate, Albireo's positive data from phase 3 trial of Odevixibat in progressive familial intrahepatic cholestasis, Corbus' disappointing results from its phase 3 trial of Lenabasum in diffuse cutaneous systemic sclerosis, and RedHill's promising 'in vitro' data of COVID-19 drug candidate.
from RTT - Biotech https://ift.tt/35ilrWk
via IFTTT
No comments:
Post a Comment